FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans
Coronavirus,FDA,Coronavirus Vaccine,Pfizer,Moderna,Science,Public Health,CDC,Omicron Variant
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.
Reporting by Michael Erman in New Jersey and Manojna Maddipatla in Bangaluru, Additional reporting by Ahmed Aboulenein in Washington; Editing by Bill Berkrot
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Bias
Media Bias Alert: DOJ Claims Biden Admin Weaponized Gov’t to ‘Chill Free Speech’ Despite Internal Dissent
Andy Gorel
October 8th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
CBS, Trump Admin Offer Competing Accounts of Texas Man's Deportation
October 26th, 2026
Recommended Reading
The State of Self-Censorship in the Classroom
AllSides Staff
October 26th, 2026
